Nanotechnology in Theranosticsand Nutraceuticals intervention for GI cancers – By Dr. Anubhab Mukherjee, Ph.D Principal Scientist | Esperer Onco Nutrition Pvt. Ltd. | R&D
MUMBAI, 4 SEPTEMBER, 2020 (GPN): Gastrointestinal (GI) cancer, the 5th most common malignancy involving epigenetic, genetic, and environmental factors withhigh rate of human demise,still remains a daunting challengeto be circumvented.Of many, MicrosatelliteInstability (MSI) triggered by DNA…